BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 19458650)

  • 1. Intravitreal delivery of AAV8 retinoschisin results in cell type-specific gene expression and retinal rescue in the Rs1-KO mouse.
    Park TK; Wu Z; Kjellstrom S; Zeng Y; Bush RA; Sieving PA; Colosi P
    Gene Ther; 2009 Jul; 16(7):916-26. PubMed ID: 19458650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Dose-Escalation Study of Intravitreal AAV-RS1 Gene Therapy in a Mouse Model of X-linked Retinoschisis: Dose-Dependent Expression and Improved Retinal Structure and Function.
    Bush RA; Zeng Y; Colosi P; Kjellstrom S; Hiriyanna S; Vijayasarathy C; Santos M; Li J; Wu Z; Sieving PA
    Hum Gene Ther; 2016 May; 27(5):376-89. PubMed ID: 27036983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synaptic pathology and therapeutic repair in adult retinoschisis mouse by AAV-RS1 transfer.
    Ou J; Vijayasarathy C; Ziccardi L; Chen S; Zeng Y; Marangoni D; Pope JG; Bush RA; Wu Z; Li W; Sieving PA
    J Clin Invest; 2015 Jul; 125(7):2891-903. PubMed ID: 26098217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal Delivery of rAAV2-hSyn-hRS1 Results in Retinal Ganglion Cell-Specific Gene Expression and Retinal Improvement in the
    Zheng Y; Xu X; Fan R; Jiang H; Guo Q; Han X; Liu Y; Luo G
    Hum Gene Ther; 2024 May; 35(9-10):342-354. PubMed ID: 38661546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Of men and mice: Human X-linked retinoschisis and fidelity in mouse modeling.
    Vijayasarathy C; Sardar Pasha SPB; Sieving PA
    Prog Retin Eye Res; 2022 Mar; 87():100999. PubMed ID: 34390869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An ex vivo gene therapy approach in X-linked retinoschisis.
    Bashar AE; Metcalfe AL; Viringipurampeer IA; Yanai A; Gregory-Evans CY; Gregory-Evans K
    Mol Vis; 2016; 22():718-33. PubMed ID: 27390514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Rescue of X-Linked Retinoschisis Mouse (
    Vijayasarathy C; Zeng Y; Brooks MJ; Fariss RN; Sieving PA
    Hum Gene Ther; 2021 Jul; 32(13-14):667-681. PubMed ID: 33019822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoschisin gene therapy and natural history in the Rs1h-KO mouse: long-term rescue from retinal degeneration.
    Kjellstrom S; Bush RA; Zeng Y; Takada Y; Sieving PA
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3837-45. PubMed ID: 17652759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoschisin gene therapy in photoreceptors, Müller glia or all retinal cells in the Rs1h-/- mouse.
    Byrne LC; Oztürk BE; Lee T; Fortuny C; Visel M; Dalkara D; Schaffer DV; Flannery JG
    Gene Ther; 2014 Jun; 21(6):585-92. PubMed ID: 24694538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural recovery of the retina in a retinoschisin-deficient mouse after gene replacement therapy by solid lipid nanoparticles.
    Apaolaza PS; Del Pozo-Rodríguez A; Solinís MA; Rodríguez JM; Friedrich U; Torrecilla J; Weber BH; Rodríguez-Gascón A
    Biomaterials; 2016 Jun; 90():40-9. PubMed ID: 26986855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptic pathology in retinoschisis knockout (Rs1-/y) mouse retina and modification by rAAV-Rs1 gene delivery.
    Takada Y; Vijayasarathy C; Zeng Y; Kjellstrom S; Bush RA; Sieving PA
    Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3677-86. PubMed ID: 18660429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical safety evaluation of a recombinant AAV8 vector for X-linked retinoschisis after intravitreal administration in rabbits.
    Marangoni D; Wu Z; Wiley HE; Zeiss CJ; Vijayasarathy C; Zeng Y; Hiriyanna S; Bush RA; Wei LL; Colosi P; Sieving PA
    Hum Gene Ther Clin Dev; 2014 Dec; 25(4):202-11. PubMed ID: 25211193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Biodistribution Evaluation of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin, in RS1-Deficient Mice.
    Ye GJ; Conlon T; Erger K; Sonnentag P; Sharma AK; Howard K; Knop DR; Chulay JD
    Hum Gene Ther Clin Dev; 2015 Sep; 26(3):177-84. PubMed ID: 26390091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RS-1 Gene Delivery to an Adult Rs1h Knockout Mouse Model Restores ERG b-Wave with Reversal of the Electronegative Waveform of X-Linked Retinoschisis.
    Zeng Y; Takada Y; Kjellstrom S; Hiriyanna K; Tanikawa A; Wawrousek E; Smaoui N; Caruso R; Bush RA; Sieving PA
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3279-85. PubMed ID: 15326152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal AAV8-RS1 Gene Therapy for X-Linked Retinoschisis: Initial Findings from a Phase I/IIa Trial by Intravitreal Delivery.
    Cukras C; Wiley HE; Jeffrey BG; Sen HN; Turriff A; Zeng Y; Vijayasarathy C; Marangoni D; Ziccardi L; Kjellstrom S; Park TK; Hiriyanna S; Wright JF; Colosi P; Wu Z; Bush RA; Wei LL; Sieving PA
    Mol Ther; 2018 Sep; 26(9):2282-2294. PubMed ID: 30196853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Road towards Gene Therapy for X-Linked Juvenile Retinoschisis: A Systematic Review of Preclinical Gene Therapy in Cell-Based and Rodent Models of XLRS.
    van der Veen I; Heredero Berzal A; Koster C; Ten Asbroek ALMA; Bergen AA; Boon CJF
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Expression of Retinoschisin by Retinal Bipolar Cells in XLRS Promotes Resolution of Retinoschisis Cysts Sans RS1 From Photoreceptors.
    Vijayasarathy C; Zeng Y; Marangoni D; Dong L; Pan ZH; Simpson EM; Fariss RN; Sieving PA
    Invest Ophthalmol Vis Sci; 2022 Oct; 63(11):8. PubMed ID: 36227606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin.
    Ye GJ; Budzynski E; Sonnentag P; Miller PE; Sharma AK; Ver Hoeve JN; Howard K; Knop DR; Neuringer M; McGill T; Stoddard J; Chulay JD
    Hum Gene Ther Clin Dev; 2015 Sep; 26(3):165-76. PubMed ID: 26390090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AAV2/4-RS1 gene therapy in the retinoschisin knockout mouse model of X-linked retinoschisis.
    Scruggs BA; Bhattarai S; Helms M; Cherascu I; Salesevic A; Stalter E; Laird J; Baker SA; Drack AV
    PLoS One; 2022; 17(12):e0276298. PubMed ID: 36477475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid lipid nanoparticle-based vectors intended for the treatment of X-linked juvenile retinoschisis by gene therapy: In vivo approaches in Rs1h-deficient mouse model.
    Apaolaza PS; Del Pozo-Rodríguez A; Torrecilla J; Rodríguez-Gascón A; Rodríguez JM; Friedrich U; Weber BH; Solinís MA
    J Control Release; 2015 Nov; 217():273-83. PubMed ID: 26400864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.